XML 10 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue:    
Total revenue $ 30,552 $ 24,933
Operating costs and expenses:    
Cost, Product and Service [Extensible Enumeration] Product Sales [Member] Product Sales [Member]
Product costs $ 8,803 $ 5,267
Research and development 8,664 12,743
Selling, general and administrative 12,537 13,236
Acquired intangible asset amortization 870 913
Contingent consideration expense   3
Total operating costs and expenses 30,874 32,162
Operating loss (322) (7,229)
Other expense:    
Interest expense, net (896) (826)
Foreign exchange loss (45) (125)
Investment income, net 539 172
Other expense, net (402) (779)
Loss before income taxes (724) (8,008)
Income tax (expense) benefit (62) 165
Net loss $ (786) $ (7,843)
Basic net loss per share $ (0.06) $ (0.56)
Diluted net loss per share $ (0.06) $ (0.56)
Weighted average number of shares outstanding:    
Basic 14,102 13,983
Diluted 14,102 13,983
Product Sales [Member]    
Revenue:    
Total revenue $ 18,827 $ 14,234
Royalties and License Fees [Member]    
Revenue:    
Total revenue 9,179 8,765
Research, Development and Other [Member]    
Revenue:    
Total revenue $ 2,546 $ 1,934